G. Pugnet

4.2k total citations
85 papers, 1.1k citations indexed

About

G. Pugnet is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Rheumatology. According to data from OpenAlex, G. Pugnet has authored 85 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Pathology and Forensic Medicine, 31 papers in Pulmonary and Respiratory Medicine and 24 papers in Rheumatology. Recurrent topics in G. Pugnet's work include Systemic Sclerosis and Related Diseases (28 papers), Vasculitis and related conditions (19 papers) and Sarcoidosis and Beryllium Toxicity Research (11 papers). G. Pugnet is often cited by papers focused on Systemic Sclerosis and Related Diseases (28 papers), Vasculitis and related conditions (19 papers) and Sarcoidosis and Beryllium Toxicity Research (11 papers). G. Pugnet collaborates with scholars based in France, Canada and Martinique. G. Pugnet's co-authors include L. Sailler, Jean‐Louis Montastruc, Guillaume Moulis, Maryse Lapeyre‐Mestre, Aurore Palmaro, L. Astudillo, Loı̈c Guillevin, Pierre Charles, Xavier Puéchal and Benjamin Terrier and has published in prestigious journals such as Blood, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

G. Pugnet

69 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Pugnet France 18 423 305 266 180 171 85 1.1k
Alessandro Giollo Italy 21 266 0.6× 557 1.8× 193 0.7× 92 0.5× 211 1.2× 90 1.5k
Narelle S Willis Australia 21 246 0.6× 137 0.4× 251 0.9× 214 1.2× 126 0.7× 31 1.5k
Damien Noone Canada 20 260 0.6× 149 0.5× 168 0.6× 167 0.9× 326 1.9× 70 1.4k
Alaa Sabry Egypt 20 161 0.4× 250 0.8× 128 0.5× 72 0.4× 184 1.1× 103 1.3k
F Mignon France 22 428 1.0× 402 1.3× 205 0.8× 234 1.3× 289 1.7× 70 1.9k
Silvana Savoldi Italy 16 292 0.7× 160 0.5× 122 0.5× 43 0.2× 90 0.5× 44 1.1k
Y. Benhamou France 22 340 0.8× 348 1.1× 89 0.3× 274 1.5× 671 3.9× 123 1.8k
Lorenzo Cavagna Italy 28 671 1.6× 727 2.4× 496 1.9× 118 0.7× 410 2.4× 119 2.2k
Ashley L. Cole United States 18 350 0.8× 117 0.4× 132 0.5× 55 0.3× 30 0.2× 52 1.1k
Mari S. Oba Japan 19 348 0.8× 68 0.2× 103 0.4× 60 0.3× 70 0.4× 103 1.3k

Countries citing papers authored by G. Pugnet

Since Specialization
Citations

This map shows the geographic impact of G. Pugnet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Pugnet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Pugnet more than expected).

Fields of papers citing papers by G. Pugnet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Pugnet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Pugnet. The network helps show where G. Pugnet may publish in the future.

Co-authorship network of co-authors of G. Pugnet

This figure shows the co-authorship network connecting the top 25 collaborators of G. Pugnet. A scholar is included among the top collaborators of G. Pugnet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Pugnet. G. Pugnet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Renaudineau, Yves, Emmanuel Treiner, Fabrice Hérin, et al.. (2025). Interferon-γ release assay as an emergent powerful biomarker in systemic lupus erythematosus. Lara D. Veeken. 64(10). 5313–5321.
2.
3.
Varenne, Fanny, et al.. (2024). Étude de vraie vie sur 6 mois d’un protocole de traitement intravitréen de la toxoplasmose oculaire par clindamycine. Journal Français d Ophtalmologie. 48(1). 104387–104387.
4.
Faguer, Stanislas, et al.. (2023). HRCT imaging of pulmonary involvement in granulomatosis with polyangiitis and microscopic polyangiitis at disease onset and during follow-up. Seminars in Arthritis and Rheumatism. 63. 152307–152307. 4 indexed citations
5.
Chaigne, Benjamin, C. Agard, Yannick Allanore, et al.. (2023). Mouth opening in systemic sclerosis: A longitudinal analysis from the French national cohort study. Journal of Internal Medicine. 294(4). 482–491. 1 indexed citations
6.
Lafaurie, Margaux, Emmanuel Treiner, Ondine Walter, et al.. (2023). Infectious risk when prescribing rituximab in patients with hypogammaglobulinemia acquired in the setting of autoimmune diseases. International Immunopharmacology. 120. 110342–110342. 3 indexed citations
7.
Pugnet, G., S. Collot, Philippe Otal, et al.. (2022). Changes on chest HRCT in systemic sclerosis-related interstitial lung disease after autologous haematopoietic stem cell transplantation. Lara D. Veeken. 62(SI). SI32–SI42. 6 indexed citations
8.
Puissant‐Lubrano, Bénédicte, D. Adoué, Laurent Alric, et al.. (2022). Clinical impact and prognosis of cryoglobulinemia and cryofibrinogenemia in systemic sclerosis. Autoimmunity Reviews. 21(8). 103133–103133. 3 indexed citations
9.
Ribes, David, Magali Colombat, Dominique Chauveau, et al.. (2021). Role of C5 inhibition in Idiopathic Inflammatory Myopathies and Scleroderma Renal Crisis–Induced Thrombotic Microangiopathies. Kidney International Reports. 6(4). 1015–1021. 12 indexed citations
10.
Pugnet, G., et al.. (2020). Off-label use of tocilizumab in neuromyelitis optica spectrum disorders and MOG-antibody-associated diseases: A case-series. Multiple Sclerosis and Related Disorders. 46. 102483–102483. 32 indexed citations
11.
Jamilloux, Yvan, Marie‐Hélène Errera, Laurent Pérard, et al.. (2020). Quality of life in patients with uveitis: data from the ULISSE study (Uveitis: cLInical and medico-economic evaluation of a Standardised Strategy for the Etiological diagnosis). British Journal of Ophthalmology. 105(7). 935–940. 6 indexed citations
12.
Brun, S., David Ribes, Eve Cariou, et al.. (2019). Cardiac magnetic resonance imaging with late gadolinium enhancement in acute myocarditis: Towards differentiation between immune-mediated and viral-related aetiologies. Archives of cardiovascular diseases. 112(10). 559–566. 6 indexed citations
13.
Dupont, Romain, Anne Galinier, Cécile Ingueneau, et al.. (2018). Impact of micronutrient deficiency & malnutrition in systemic sclerosis: Cohort study and literature review. Autoimmunity Reviews. 17(11). 1081–1089. 25 indexed citations
14.
Pugnet, G., Zora Marjanovic, C. Deligny, et al.. (2018). Reproducibility and Utility of the 6-minute Walk Test in Systemic Sclerosis. The Journal of Rheumatology. 45(9). 1273–1280. 18 indexed citations
15.
16.
Pugnet, G., L. Sailler, Jean‐Pascal Fournier, et al.. (2016). Predictors of Cardiovascular Hospitalization in Giant Cell Arteritis: Effect of Statin Exposure. A French Population-based Study. The Journal of Rheumatology. 43(12). 2162–2170. 20 indexed citations
17.
Pugnet, G., L. Sailler, Robert Bourrel, Jean‐Louis Montastruc, & Maryse Lapeyre‐Mestre. (2014). Is Statin Exposure Associated with Occurrence or Better Outcome in Giant Cell Arteritis? Results from a French Population-based Study. The Journal of Rheumatology. 42(2). 316–322. 21 indexed citations
18.
Jamilloux, Yvan, Eric Liozon, G. Pugnet, et al.. (2013). Recovery of Adrenal Function after Long-Term Glucocorticoid Therapy for Giant Cell Arteritis: A Cohort Study. PLoS ONE. 8(7). e68713–e68713. 44 indexed citations
19.
Sailler, L., G. Pugnet, & Boris Bienvenu. (2013). Traitement de la maladie de Horton. La Revue de Médecine Interne. 34(7). 431–437. 8 indexed citations
20.
Astudillo, L., et al.. (2008). Une maladie de Wegener avec des signes d’artérite temporale. La Revue de Médecine Interne. 29(10). 830–831. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alessandro Giollo Breakdown of academic impact, for papers by Narelle S Willis Breakdown of academic impact, for papers by Damien Noone Breakdown of academic impact, for papers by Alaa Sabry Breakdown of academic impact, for papers by F Mignon Breakdown of academic impact, for papers by Silvana Savoldi Breakdown of academic impact, for papers by Y. Benhamou Breakdown of academic impact, for papers by Lorenzo Cavagna Breakdown of academic impact, for papers by Ashley L. Cole Breakdown of academic impact, for papers by Mari S. Oba
Rankless by CCL
2026